Cord blood V2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity

Journal of Infectious Diseases

Volumn 209, Issue 10, 2014, Pages 1653-1662

  Cairo, Cristiana ^a   Longinaker, Nyaradzo ^b   Cappelli, Giulia ^c,f   Leke, Rose G F ^d   Ondo, Manuel O ^c   Djokam, Rosine ^d   Fogako, Josephine ^d   Leke, Robert J ^e   Sagnia, Bertrand ^c   Sosso, Samuel ^c   Colizzi, Vittorio ^c,g   Pauza, C David ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Chantal Biya International Reference Center for Research on HIV AIDS Prevention and Management   (United States)

^d University of Yaounde I   (France)

^e YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^f National Council of Research Institute of Translational Pharmacology   (United States)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

aminobisphosphonate; cord blood; gammadelta; innate; neonatal; phosphoantigen; placental malaria; Plasmodium; repertoire

Indexed keywords

MOLECULAR MARKER; PARASITE ANTIGEN; BIOLOGICAL MARKER; IMMUNOGLOBULIN HEAVY CHAIN; PHOSPHOANTIGEN;

ARTICLE; BLOOD SAMPLING; CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; EX VIVO STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNOPHENOTYPING; INNATE IMMUNITY; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA FALCIPARUM; MALE; MEMORY T LYMPHOCYTE; METABOLITE; MONONUCLEAR CELL; NEWBORN; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD; VGAMMA2 VDELTA2 T LYMPHOCYTE; AMINOBISPHOSPHONATE; CYTOLOGY; FEMALE; FETUS BLOOD; GAMMADELTA; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE; METABOLISM; NEONATAL; PASSIVE IMMUNIZATION; PHYSIOLOGY; PLACENTA MALARIA; PLASMODIUM; PREGNANCY COMPLICATION; REPERTOIRE;

AMINOBISPHOSPHONATE; CORD BLOOD; GAMMADELTA; INNATE; NEONATAL; PHOSPHOANTIGEN; PLACENTAL MALARIA; PLASMODIUM; REPERTOIRE;

BIOLOGICAL MARKERS; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN GAMMA-CHAINS; INFANT, NEWBORN; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; T-LYMPHOCYTE SUBSETS;

EID: 84899495960     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit802     Document Type: Article

References (50)

1. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012; 12:330-40.
2. Labeaud AD, Malhotra I, King MJ, King CL, King CH. Do antenatal parasite infections devalue childhood vaccination? PLoS Negl Trop Dis 2009; 3:e442.
3. Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446-54.
4. Walther B, Miles DJ, Waight P, et al. Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination. BMC Infect Dis 2012; 12:6.
5. Le Hesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol 1997; 146:826-31.
6. Malhotra I, Dent A, Mungai P, et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med 2009; 6:e1000116.
7. Malhotra I, Mungai PL, Wamachi AN, et al. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis 2006; 193:1005-13.
8. Malhotra I, Mungai P,Wamachi A, et al. Helminth-and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162:6843-8.
9. Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995; 3:495-507.
10. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995; 375:155-8.
11. Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 2003; 544:4-10.
12. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197:163-8.
13. Cairo C, Mancino G, Cappelli G, et al. Vdelta2 T-lymphocyte responses in cord blood samples from Italy and Cote d'Ivoire. Immunology 2008; 124:380-7.
14. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96:384-92.
15. Moens E, Brouwer M, Dimova T, Goldman M,Willems F, Vermijlen D. IL-23R and TCR signaling drives the generation of neonatal V{gamma} 9V{delta}2 T cells expressing high levels of cytotoxic mediators and producing IFN-{gamma} and IL-17. J Leukoc Biol 2011; 89:743-52.
16. Lang F, Peyrat MA, Constant P, et al. Early activation of human V gamma 9 V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol 1995; 154:5986-94.
17. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993; 61:197-203.
18. Conti L, Casetti R, Cardone M, et al. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 2005; 174:252-60.
19. Martino A, Casetti R, D'Alessandri A, Sacchi A, Poccia F. Complementary function of gamma delta T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens. J Clin Immunol 2005; 25:230-7.
20. Gertner-Dardenne J, Bonnafous C, Bezombes C, et al. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies. Blood 2009; 113:4875-84.
21. Capietto AH, Martinet L, Fournie JJ. Stimulated gammadelta T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer. J Immunol 2011; 187:1031-8.
22. Maniar A, Zhang X, Lin W, et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 2010; 116:1726-33.
23. Cairo C, Sagnia B, Cappelli G, et al. Human cord blood gammadelta T cells expressing public Vgamma2 chains dominate the response to bisphosphonate plus interleukin-15. Immunology 2013; 138:346-60.
24. Mazzola TN, Da Silva MT, Moreno YM, et al. Robust gammadelta+ T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 2007; 25:6313-20.
25. Tastan Y, Arvas A, Demir G, Alikasifoglu M, Gur E, Kiray E. Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell]. Pediatr Allergy Immunol 2005; 16:624-9.
26. Goerlich R, Hacker G, Pfeffer K, Heeg K, Wagner H. Plasmodium falciparum merozoites primarily stimulate the V gamma 9 subset of human gamma/delta T cells. Eur J Immunol 1991; 21:2613-6.
27. Behr C, Poupot R, Peyrat MA, et al. Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun 1996; 64:2892-6.
28. Costa G, Loizon S, Guenot M, et al. Control of Plasmodium falciparum erythrocytic cycle: gammadelta T cells target the red blood cell-invasive merozoites. Blood 2011; 118:6952-62.
29. Elloso MM, van der Heyde HC, vandeWaa JA, Manning DD,Weidanz WP. Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells. J Immunol 1994; 153:1187-94.
30. Troye-Blomberg M, Worku S, Tangteerawatana P, et al. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand J Immunol 1999; 50:642-50.
31. Martini F, Paglia MG, Montesano C, et al. V gamma 9 V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection. Infect Immun 2003; 71:2945-9.
32. Roussilhon C, Agrapart M, Guglielmi P, Bensussan A, Brasseur P, Ballet JJ. Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol 1994; 95:91-7.
33. Schwartz E, Shapiro R, Shina S, Bank I. Delayed expansion of V delta 2+ and V delta 1+ gamma delta T cells after acute Plasmodium falciparum and Plasmodium vivax malaria. J Allergy Clin Immunol 1996; 97:1387-92.
34. D'Ombrain MC, Hansen DS, Simpson KM, Schofield L. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. Eur J Immunol 2007; 37:1864-73.
35. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 2010; 184:6043-52.
36. Cairo C, Propp N, Auricchio G, et al. Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. Mol Immunol 2008; 45:3190-7.
37. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunology 2001; 104:19-27.
38. Davodeau F, Peyrat MA, Hallet MM, et al. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J Immunol 1993; 151:1214-23.
39. Davodeau F, Peyrat MA, Hallet MM, Houde I, Vie H, Bonneville M. Peripheral selection of antigen receptor junctional features in a major human gamma delta subset. Eur J Immunol 1993; 23:804-8.
40. Morita CT, Parker CM, Brenner MB, Band H. TCR usage and functional capabilities of human gamma delta T cells at birth. J Immunol 1994; 153:3979-88.
41. Parker CM, Groh V, Band H, et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med 1990; 171:1597-612.
42. Riedel DJ, Sajadi MM, Armstrong CL, et al. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. AIDS 2009; 23:1955-64.
43. Cairo C, Armstrong CL, Cummings JS, et al. Impact of age, gender, and race on circulating gammadelta T cells. Hum Immunol 2010; 71:968-75.
44. Delfau MH, Hance AJ, Lecossier D, Vilmer E, Grandchamp B. Restricted diversity of V gamma 9-JP rearrangements in unstimulated human gamma/delta T lymphocytes. Eur J Immunol 1992; 22:2437-43.
45. Li B, Bassiri H, Rossman MD, et al. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161:1558-67.
46. Engelmann I, Moeller U, Santamaria A, Kremsner PG, Luty AJ. Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population. Immunology 2006; 119:515-21.
47. Engelmann I, Santamaria A, Kremsner PG, Luty AJ. Activation status of cord blood gamma delta T cells reflects in utero exposure to Plasmodium falciparum antigen. J Infect Dis 2005; 191:1612-22.
48. Adegnika AA, Kohler C, Agnandji ST, et al. Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood. J Infect Dis 2008; 198:928-36.
49. Broen K, Brustoski K, Engelmann I, Luty AJ. Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol 2007; 151:1-8.
50. Laufer MK, Thesing PC, Eddington ND, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006; 355:1959-66.